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Abstract 
Background: Anomalies in myocardial structure involving myocyte growth, hypertrophy, differentiation, apopto‑
sis, necrosis etc. affects its function and render cardiac tissue more vulnerable to the development of heart failure. 
Although oxidative stress has a well‑established role in cardiac remodeling and dysfunction, the mechanisms linking 
redox state to atrial cardiomyocyte hypertrophic changes are poorly understood. Here, we investigated the role of 
nuclear erythroid‑2 like factor‑2 (Nrf2), a central transcriptional mediator, in redox signaling under high intensity exer‑
cise stress (HIES) in atria.
Methods: Age and sex‑matched wild‑type (WT) and Nrf2−/− mice at >20 months of age were subjected to HIES for 
6 weeks. Gene markers of hypertrophy and antioxidant enzymes were determined in the atria of WT and Nrf2–/– mice 
by real‑time qPCR analyses. Detection and quantification of antioxidants, 4‑hydroxy‑nonenal (4‑HNE), poly‑ubiquitina‑
tion and autophagy proteins in WT and Nrf2−/− mice were performed by immunofluorescence analysis. The level of 
oxidative stress was measured by microscopical examination of di‑hydro‑ethidium (DHE) fluorescence.
Results: Under the sedentary state, Nrf2 abrogation resulted in a moderate down regulation of some of the atrial 
antioxidant gene expression (Gsr, Gclc, Gstα and Gstµ) despite having a normal redox state. In response to HIES, 
enlarged atrial myocytes along with significantly increased gene expression of cardiomyocyte hypertrophy markers 
(Anf, Bnf and β‑Mhc) were observed in Nrf2−/− when compared to WT mice. Further, the transcript levels of Gclc, Gsr 
and Gstµ and protein levels of NQO1, catalase, GPX1 were profoundly downregulated along with GSH depletion and 
increased oxidative stress in Nrf2−/− mice when compared to its WT counterparts after HIES. Impaired antioxidant 
state and profound oxidative stress were associated with enhanced atrial expression of LC3 and ATG7 along with 
increased ubiquitination of ATG7 in Nrf2−/− mice subjected to HIES.
Conclusions: Loss of Nrf2 describes an altered biochemical phenotype associated with dysregulation in genes 
related to redox state, ubiquitination and autophagy in HIES that result in atrial hypertrophy. Therefore, our findings 
direct that preserving Nrf2‑related antioxidant function would be one of the effective strategies to safeguard atrial 
health.
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Background
Heart failure is a leading health problem with over 
500,000 new cases and  ~300,000 deaths annually in the 
United States [1]. The pathophysiology of heart and car-
diovascular diseases such as heart failure, coronary heart 
disease, cardiomyopathy, fibrosis, ventricular hypertro-
phy, atrial fibrillation etc. is closely connected to redox 
imbalance [2, 3]. Oxidative changes not only prompt 
molecular conformation of proteins, lipids, and nucleic 
acids but also elaborate the signals involved in the propa-
gation of structural remodeling of cells and tissues. In 
relevance, the burst of oxidative species generated from 
cardiomyocytes and endothelial cells magnifies the 
inflammatory signals and together they commence a cas-
cade of downstream events [4]. These signaling events, in 
turn, affect the cardiac structures and electrical modeling 
thus initiating, steering and/or promoting atrial remod-
eling [5]. Of note, this remodeling could either be adap-
tive or maladaptive regulation of cardiac myocytes and 
other cells in the atria that is dependent on the length of 
exposure to oxidative stress. The significance and patho-
genic consequences of chronic oxidative stress (COS) and 
ventricular dysfunction in failing hearts have received 
much clinical attention [6, 7]. Interestingly, some studies 
indicate that atrial changes could be an important causal 
mechanism for ventricular dysfunction since  ~20  % of 
left ventricular stroke volume at rest is attributed to atrial 
contraction [2, 7–9]. It has been described that atrio-
ventricular interaction is in a vicious cycle, i.e., change 
in atria can affect ventricle and vice versa [10]. Thus, 
a maladaptive atrial structural change could serve as a 
central cause for a spectrum of pathophysiological pro-
cesses associated with cardiac failure [11]. In addition, 
the limited efficacy and serious off-target adverse effects 
challenge the current therapeutic management of atrial 
remodeling. Despite an existence of a clear association 
between oxidative stress and atrial pathophysiologi-
cal changes [12], the mechanisms underlying the atrial 
remodeling is still poorly understood.
Transcriptional regulation of antioxidant genes by 
specific endogenous factors has been gaining increasing 
attention [13, 14]. Of interest, Nrf2 has been recognized 
as a master transcriptional regulator of antioxidant genes 
[15, 16]. Activated Nrf2 binds to the antioxidant/electro-
phile response element (ARE/EpRE) in the promoter of 
target antioxidant genes and regulates their transcription 
[17]. Numerous studies have demonstrated that loss and/
or dysregulation of Nrf2 are often linked with various 
diseases [18–21]. Davies and co-workers have demon-
strated that habitual exercise training decreases oxida-
tive stress [22–24] and recent studies from our laboratory 
has shown that acute exercise activates Nrf2/ARE sign-
aling promoting the antioxidant defense genes in the 
myocardium [25]. However, the role of Nrf2 signaling in 
response to high endurance activity in the atria has not 
been investigated. In eukaryotic cells, autophagy mecha-
nism is typically used to deliver cytoplasmic proteins and 
organelles to lysosomes [26, 27]. It is augmented during 
cell growth, development, and death and has been associ-
ated with several pathological conditions such as cancer, 
neurodegenerative disorders, myopathies, heart and liver 
diseases, and gastrointestinal disorders [28]. However, 
the autophagic activity is shown to decline with increas-
ing age that in turn leads to dampened response to stress 
and thus, inefficient clearance of damaged proteins and 
organelles in cells and tissues [29]. Herein, the autophagic 
response was estimated in terms of measuring the levels 
of LC3, an important regulator that initiates autophago-
some biogenesis and Atg7, a key autophagy promoting 
molecule [30].
In this study, our goal was to examine the effect of high-
intensity exercise stress (HIES) on redox-sensitive, Nrf2 
signaling in atria of age and sex matched >20 months old 
wild-type (WT) and mice genetically engineered to lack 
Nrf2 (Nrf2−/−). The study tests the hypothesis that genetic 
disruption or abrogation of Nrf2 in association with high-
intensity exercise stress (HIES) could induce atrial remod-
eling on aging. Given a high predictive value of oxidative 
stress markers in myocardial injury, fibrosis and cardiac 
muscle damage as well as a wide knowledge gap with 
respect to mechanistic understanding of pathological 
remodeling, our current study will present the biochemical 
basis of Nrf2 signaling mechanism in the process of atrial 
cardiomyocyte remodeling that ensue with age-associated 
oxidative challenge [31]. Further, it will enhance our abil-
ity to target the Nrf2 signaling as a potential therapeutic 
direction and help develop therapeutic agents to control 
the pathogenesis associated with aging atria.
Methods
Animals
C57/BL6/SJ wild-type (WT) and Nrf2 knock out 
(Nrf2−/−) (C57/BL6/SJ background) mice (>20  months 
of age) were used to study the effect of redox imbalances 
in atria. Mice were obtained from Dr. Li Wang (Univer-
sity of Utah, USA). The animals were maintained in the 
Small Animal Housing and Research Facility at Univer-
sity of Utah. Mice were housed not more than n  =  5/
cage with free access to food (standard rodent diet) and 
water ad  libitum and maintained under conditions con-
trolled for temperature and humidity, artificial lighting 
for 12-h from 6 AM to 6 PM light/dark cycle. The animal 
exercise and usage protocols were approved by Institu-
tional Animal Care and Use Committee (IACUC) of Uni-
versity of Utah and then by the University of Alabama at 
Birmingham.
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High‑intensity exercise program
Wild-type and Nrf2−/− mice (n   =   3–4/group/experi-
ment) were randomly assigned for high-intensity exer-
cise (HIES) on a treadmill as described previously [32]. 
The HIES protocol was developed based on our previ-
ous exercise protocols ranging from acute-moderate, 
acute-endurance, short-term moderate and long-term 
endurance regimen [18, 25, 32, 33]. Briefly, HIES mice 
were run on the treadmill for 6 weeks at 20–25 m/min; 
12 % grade for 60 min per day. Before subjecting the mice 
for HIES, they were trained for 1 week on the treadmill 
for 10  min; 15–22  m/min; 0–12  % grade to check their 
endurance ability. Equal numbers of mice were assigned 
to the sedentary group and were not subjected to HIES. 
After 6 weeks of HIES, mice were sacrificed by CO2 inha-
lation and tissues were harvested after 3 h following the 
last bout of exercise. Left and right atria were carefully 
dissected out by removing ventricles, aorta and fat bodies 
using a dissection microscope. Then the atria were stored 
either in RNA later (Sigma) followed by frozen at −80 °C 
or embedded in O.C.T media and flash frozen in liquid 
nitrogen and stored for subsequent analyses.
RNA isolation, reverse transcription and qRT‑PCR
Atrial RNA from WT and Nrf2−/− mice (HIES and sed-
entary) was extracted using Qiagen kit (74106) follow-
ing the manufacturer’s instructions. 1.25 μg of RNA was 
used to synthesize cDNA (Qiagen Reverse Transcription 
Kit #205311) and 25–50 ng of cDNA template in a final 
reaction mixture of 10  µL of SYBR green master mix 
(Qiagen #204054) and respective primer sets (1  pmol) 
(Table 1) was PCR amplified in a Light Cycler real-time 
thermocycler (Roche Light Cycler-480). Quantifica-
tion of mRNA  was done using Ct values, and the tar-
get mRNA levels were calculated by normalizing to the 
Ct values of housekeeping genes Arbp1 or Gapdh by 2−
ΔΔCt method [34].
Wheat germ agglutinin staining (WGA)
10  μm cryostat sections of atrial tissues from all the 
experimental animals were fixed in 4  % paraformalde-
hyde for 15 min and followed by three washes with PBS. 
Then the tissue sections were labeled with 5  µg/ml of 
WGA in PBS, wheat germ agglutinin, oregon green 488 
Conjugate (W6748, Molecular Probes, Inc.) for 30  min 
in a light protected chamber maintained at 37  °C incu-
bator for 30  min. Slides were then washed in PBS and 
fixed with fluoroshield mounting medium with DAPI 
(ab104139, Abcam, Cambridge, MA, USA) and the 
images were captured using a confocal laser microscope 
(Nikon A1Confocal, Nikon Instruments Inc.) using a 
60× objective [35].
Immunofluorescent detection of antioxidants, 
ubiquitination and autophagy proteins in atria
For the immunofluorescent staining, the atrial tissues col-
lected from all the experimental groups were embedded 
in O.C.T freezing medium followed by 10  μm  section-
ing on a cryostat. Tissue sections were incubated with 
4 % paraformaldehyde for 15 min and washed thrice with 
PBS. Then the sections were permeabilized with 0.25  % 
Triton X-100 and washed thrice with PBS. The tissue sec-
tions were then incubated with PBS containing 5 % normal 
horse serum for 1 h to block nonspecific binding of anti-
bodies. Sections were then incubated with respective pri-
mary antibodies for 1 h at room temperature or overnight 
at 4 °C. The following concentrations for primary antibod-
ies were used: rabbit/mouse anti-GCLC (1:500; ab41463, 
Table 1 List of the primers used for the qRT-PCR analysis
Genes name Sequences (5′…..3′)
Anf F GCTTCCAGGCCATATTGGAG 
Anf R GGGGGCATGACCTCATCTT 
Arbp1 F TGAGATTCGGGATATGCTGTTGG 
Arbp1 R  CGGGTCCTAGACCAGTGTTCT 
α‑Mhc F GAGTGGGAGTTTATCGACTTCG 
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Abcam, Cambridge, MA, USA); rabbit anti-NQO1 (1:500; 
ab34173, Abcam, Cambridge, MA, USA), rabbit anti-
GSTμ (1:500; ab178684, Abcam, Cambridge, MA, USA), 
rabbit anti-GSR (1:500; ab16801, Abcam, Cambridge, MA, 
USA), rabbit anti-4-HNE (1:500; 393207, Calbiochem, 
EMD Millipore Corporation, Billerica, MA), rabbit anti-
Ubiquitin (1:500; ab7780, Abcam, Cambridge, MA, USA), 
rabbit LC-3 (1:500; D3U4C, Cell Signaling Technology, 
Danvers, MA, USA), rabbit p62 (1:500; ab91526, Abcam, 
Cambridge, MA, USA), rabbit ATG-7 (1:500; D12B11,Cell 
Signaling Technology, Danvers, MA, USA). In some exper-
iments, tissue sections were sequentially  double-stained 
with rabbit anti-ATG-7 primary antibody (1:500; D12B11, 
Cell Signaling Technology, Danvers, MA, USA) and incu-
bated overnight at 4  °C, followed by 1 h incubation with 
the secondary antibody Alexa fluor 594 goat anti-rabbit 
IgG (H+L) (1: 1000; A11037, Life Technologies Corpora-
tion, NY, USA) at room temperature for 1 h in dark. Sec-
tions were then washed thrice with PBS and incubated 
with second-primary antibody, rabbit anti-Ubiquitin 
(1:500; ab7780, Abcam, Cambridge, MA, USA) for 2 h at 
room temperature. All sections following primary anti-
body incubation were washed with PBS thrice and then 
incubated in secondary antibody Alexa fluor 488 goat anti-
rabbit IgG (H+L) (1: 1000; A11008, Life Technologies Cor-
poration, NY, USA) for 1 h in the dark. Thereafter, sections 
were thoroughly washed thrice for 10  min with PBS in 
dark and fluoroshield/DAPI mounted (ab104139, Abcam, 
Cambridge, MA, USA) specimens were imaged on a con-
focal laser-scanning microscope (Nikon A1Confocal, 
Nikon Instruments Inc.) by using a 60× objective [13]. At 
least, 3–4 micrographs per tissue were obtained and calcu-
lated the appropriate intensity for each target.
Determination of glutathione (GSH) 
by immunofluorescence
For the anti-GSH immunofluorescent staining, the atrial 
tissues collected from all the experimental groups were 
embedded, fixed and permeabilized as above. Sections 
were then incubated in ethanol containing 10 mM N-Eth-
ylmaleimide (NEM) [36] for 30  min and washed three 
times with PBS. After blocking with 1 M PBS containing 
5 % normal horse serum for 1 h, sections were incubated 
for overnight at 4 °C with primary antibody (mouse anti-
Glutathione: N- Ethylmaleimide; 1:500; MAB3194, EMD 
Millipore Corporation, Billerica, MA). After appropriate 
staining with secondary antibody conjugated with Alexa-
Flour-488, sections were then mounted and imaged using 
a confocal microscope.
Measurement of ROS production using DHE staining
The level of ROS was measured using a lipophilic, cell-
permeable fluorogenic dye, DHE (di-hydro ethidium), 
which undergoes oxidation to ethidium bromide or struc-
turally similar products in the presence of superoxide 
that binds with double stranded DNA yielding a red fluo-
rescent signal [37]. Briefly, atria were collected from the 
different groups and were placed in O.C.T. medium and 
frozen in −80 °C. 10 μm thick atrial sections were placed 
on slides and incubated with 5 μg/ml of DHE in PBS in 
a light protected chamber maintained at 37  °C incuba-
tor for 30  min. Slides were then fixed with fluoroshield 
mounting medium with DAPI (ab104139, Abcam, Cam-
bridge, MA, USA) and the images were captured by ran-
domly selecting 3–5 fields/section were obtained using a 
Nikon A1 confocal microscope (Nikon Instruments Inc.) 
and 60×  objective. The pixel densities of the digitized 
fluorescent images were quantified using ImageJ (NIH). 
Relative changes of DHE fluorescence were expressed as 
fold change over WT sedentary group.
Statistical analysis
Mean values for relative gene expression and relative 
fold change for protein level were calculated and the data 
points were expressed as mean ±  SEM for n  =  3–4 in 
each experimental group. Statistical analysis for the com-
parison between the treatment and control groups was 
performed by one-way ANOVA using Graph-Pad Prism 
software. Statistical significance was indicated where 
P < 0.05.
Results
Genetic ablation of Nrf2 promotes hypertrophy associated 
remodeling of the atria in late middle‑aged equivalent 
mice
Nrf2-antioxidant signaling declines with advancing age 
[18, 38] and the mice used herein are between 20 and 
22 months, the human equivalent of 60+ years represent-
ing late middle age. The significant finding of the current 
study is that the loss of Nrf2 in conjunction with a high 
intensity exercise stress (HIES) perturbation induced sig-
nificant changes in atrial remodeling. After 6-weeks of 
HIES, the mRNA levels of key markers of hypertrophy 
(Anf, Bnf, α-Mhc and β-Mhc) were significantly (P < 0.05) 
altered in atria of Nrf2−/− in relation to WT mice. In sed-
entary mice, the gene expression of these markers was 
comparable between the WT and Nrf2−/− atria. On the 
other hand, there was a notable difference in the animals 
that were subjected to HIES. A significant transcript 
abundance of Anf (~80 %; P < 0.05), Bnf (75 %; P < 0.05) 
and β-Mhc (50  %; P  <  0.05) was observed in Nrf2−/− 
when compared to WT mice that underwent HIES 
(Fig.  1a). Interestingly, while HIES significantly elevated 
the Anf and Bnf transcripts in WT animals, the levels of 
α-Mhc and β-Mhc were not altered. The greater degree 
of upregulation of the hypertrophy markers seen in 
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Nrf2−/− mice in response to HIES could possibly indicate 
an early molecular sign of atrial abnormality. Following 
an increase in a subset of hypertrophy markers, we next 
examined if there is any cell size variation of atria using 
wheat germ agglutinin (WGA) staining that delineates 

































































































Fig. 1 Analysis of gene expression and hypertrophy in the atria of WT and Nrf2−/− mice upon HIES. a After 4‑weeks of high intensity endurance 
exercise (HIES), atria were isolated from SED and HIES (n = 4–6/group) mice. Transcript (mRNA) levels of hypertrophy markers (Anf, Bnf, α‑Mhc and 
β‑Mhc) by qRT‑PCR was analyzed and relative gene expression was calculated using Gapdh as a house‑keeping gene. b Immunofluorescence 
images showing atrial hypertrophy in HIES WT and Nrf2−/−. Cryo‑sections from atrial tissues were fixed and stained with wheat germ agglutinin 
(WGA) and imaged using confocal microscopy (60 × oil immersion). c WGA staining showing the borders of atrial cardiomyocytes with cell mem‑
brane in green and DAPI stains nucleus in blue‑enlarged (hypertrophy) cardiomyocytes are highlighted. d Cell size was quantified by measuring area 
using ImageJ software (n = 30–45 cells/group). Data is presented in the histograms (mean ± SEM). *P < 0.05 vs SED WT; #P < 0.05 vs SED Nrf2−/− 
and $P < 0.05 vs HIES WT
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there was no obvious change in the cell size of the atrial 
myocardium of Nrf2−/− mice when compared to the WT 
under sedentary state (Fig.  1b, left top vs right top and 
c). However, a clear cell size variation with an increase 
in large and medium-sized cells was noted in the atria 
of Nrf2−/− mice compared to wild type littermate sub-
jected to HIES (Fig. 1b, left bottom vs right bottom and 
c). Image J quantification of cardiomyocyte cross-sec-
tional size of Nrf2−/− subjected to HIES was normalized 
to WT cells, illustrating significantly larger atrial cell size 
from Nrf2−/− (P < 0.05; Fig. 1d, column 3 vs 4) and thus, 
an atrial structural defect. Overall, these results demon-
strate that mice lacking Nrf2 when challenged with HIES 
can undergo unsought atrial remodeling.
Ablation or decline in Nrf2 downregulates the 
transcription of major antioxidant genes in response 
to HIES
Under the sedentary condition, the atrial mRNA expres-
sion for Gclc, Gsr, Gst-µ, Gst-α and Sod1 were moder-
ately down-regulated in Nrf2-knockout versus WT mice 
(Fig.  2), suggesting the expected decline of antioxidants 
transcription due to advancing age [38]. In response 
to HIES, the mRNA levels of Gclc, Gsr, Gst-µ, Gst-α 
and Sod1 were significantly down-regulated in both the 
groups indicating decreased or blunted trans-activation 
of Nrf2-dependent antioxidant genes (Fig.  2). Interest-
ingly the degree of down-regulation in some of the genes 
(Gsr, Gst-µ, Gst-α) was magnified in Nrf2−/− when com-
pared to WT mice, which reveals the selective loss-of-
function effect for Nrf2. Nevertheless, these observations 
suggest that the WT mice at the age of >20 months dis-
play compromised antioxidant systems in response to 
HIES which could be greatly affected by an absence of 
Nrf2 as reported previously [32].
Impaired antioxidants protein expression is evident 
in Nrf2−/− mice atria under sedentary and/or HIES
To test if the changes in Nrf2 target gene expression 
are reflected at the protein levels, we analyzed protein 
expression of selected antioxidant enzymes that are 
involved in GSH metabolism and redox homeostasis 
using immunofluorescence. The tested antioxidant pro-
teins, such as GCLC (1.0 vs 0.5 in Nrf2−/−), NQO1 (1.0 vs 
0.62 in Nrf2−/−), GSR (1.0 vs 0.67 in Nrf2−/−) and GST-µ 
(1.0 vs 0.25 in Nrf2−/−) were significantly (P  <  0.05) 
decreased in the atria of  >20–22  months old Nrf2−/− 
mice when compared to age-matched WTs under a 
sedentary condition (Fig. 3a, b). In addition, HIES chal-
lenge to WT animals significantly decreased (GCLC and 
GSTµ) or increased (NQO1 and GSR) the expression of 
the selected antioxidant proteins in atria (P < 0.05) when 
compared to WT sedentary animals (Fig. 3a, b, column 1 
vs 3). These observations indicate a differential response 
in regulating antioxidant proteins by HIES in aged WT 
mice. Akin to the changes observed in gene expression, 
the expression of GCLC was further decreased in the 
atria of Nrf2−/− mice in response to HIES when com-
pared with WT-HIES counterparts (Fig.  3a, b), suggest-
ing that the effect of HIES is exacerbated in the absence 
of Nrf2. Further, such a dramatic decrease in response to 
HIES in Nrf2−/− atria might be responsible for regulation 
of the intracellular glutathione levels.
Impaired intracellular glutathione levels in Nrf2−/− 
and HIES mouse atria
Since we observed a proportional decrease in the levels 
of GCLC, a GSH biosynthetic enzyme, and GSR, a GSH 
recycle enzyme in Nrf2−/− mice subjected to HIES, we 
next examined the levels of GSH under the same experi-
mental setup. In sedentary conditions, the NEM-incu-
bated atrial sections from WT animals showed a mild 
to moderate level of staining of GSH-NEM (Fig. 4a) that 
was not significantly different in Nrf2−/− atria (Fig.  4a, 
b), suggesting the levels of reduced form of GSH is unaf-
fected in the unstressed condition. On the other hand, 
the Nrf2−/− animals subjected to HIES showed a dra-
matic reduction in GS-NEM staining. In particular, when 
compared to HIES challenged WT animals, a clear and 
significant reduction by  ~60  % in the atrial GSH-NEM 
staining pattern was noted in HIES challenged Nrf2-
deficient mice (P  <  0.05; Fig.  4b, column 3 vs 4) imply-
ing that the reserve of reduced GSH could be profoundly 
impaired during a stress challenge in the absence of Nrf2 
and advancing age.
Loss of Nrf2 magnifies oxidative stress in response to HIES
Next, we evaluated whether the decrease in GSH after 
HIES in Nrf2−/− animals accompany an oxidant load 
using a small molecule probe, di-hydro ethidium (DHE). 
DHE staining revealed that WT and Nrf2−/− ablated atria 
was not significantly different under the non-stressed 
sedentary state (Fig. 4c, d). However, over 30 % increase 
in atrial DHE staining was observed in WT animals 
exposed to HIES (Fig. 4c, d, column 1 vs 3) indicating an 
increase in reactive oxygen species (ROS) levels. Further, 
a doubled increase in superoxide levels marked by DHE 
staining was observed in Nrf2-deficient HIES animals 
versus WT-HIES (Fig. 4d, column 3 vs 4) illustrating that 
HIES could perturb and tilt the redox balance towards 
severe oxidative stress in atria when Nrf2 is abrogated. 
ROS-induced phospholipid peroxidation can lead to the 
formation of HNE that in turn can form stable covalent 
protein adducts and aggravate the pathological processes 
in the cardiovascular system [39]. As shown in Fig.  5a, 
under sedentary conditions, atria from Nrf2−/− mice 
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Fig. 2 Deregulation of antioxidant genes expression in the atria of WT and Nrf2−/− mice in response to HIES. Quantitative RT‑PCR determination 
of RNA message for Nrf2/ARE‑regulated antioxidant genes in the atria of SED and HIES (WT and Nrf2−/−, n = 4–6/group) mice. The respective Ct 
values were normalized to the Gapdh expression and the relative differences in target gene level were determined using the arithmetic formula  
2−ΔΔCt. The results are presented as mean ± SEM of WT‑sedentary. *P < 0.05 vs SED WT; #P < 0.05 vs SED Nrf2–/– and $P < 0.05 vs HIES WT
































Fig. 3 Immunofluorescence analyses of the antioxidant enzymes in the atria of WT and Nrf2–/– mice. a IF analysis of representative antioxidant 
enzymes (GCLC, NQO1, GSTµ and GSR) from cryo‑sections of atria from WT and Nrf2–/– mice (n = 3 – 4/group) under sedentary and after HIES. b 
Representative fluorescence intensity analyses of the immune‑reactive signals obtained for the respective antioxidant enzymes. *P < 0.05 vs SED 
WT; #P < 0.05 vs SED Nrf2–/– and $P < 0.05 vs HIES WT
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Fig. 4 Quantification of reduced glutathione (GSH) and ROS levels by DHE by immunofluorescence: a IF analysis using anti‑GSH‑NEM adduct‑ab 
(1:500; v/v) showing decreased GSH levels in WT and Nrf2−/− under sedentary and after HIES. Blue: nucleus (DAPI); Green: Anti‑GSH staining. b 
Intensity analysis of the Anti‑GSH staining. c Atrial tissue sections treated with cell‑permeable DHE, the oxidized, fluorescent 2‑hydroxyethidium 
(Red: DHE; Blue: DAPI). Images were obtained using confocal microscope at a magnification of 60x oil immersion. d ROS intensity was quantified 
using ImageJ Software and calculated as fold change of mean values of the WT sedentary group and the data is represented as mean ± SEM in the 
histograms (n = 3/group). *P < 0.05 vs SED WT; #P < 0.05 vs SED Nrf2−/− and $P < 0.05 vs HIES WT
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displayed a significantly higher level of 4HNE-Michael 
adducts when compared to WT animals suggesting that 
Nrf2 do modulate basal HNE modification of proteins 
due to advancing age. In addition, HIES exposure to WT 
animals resulted in a relatively moderate, yet signifi-
cant increase in HNE-Michael adducts when compared 
to WT-sedentary animals (Fig.  5b, column 1 vs 3). On 
the other hand, immunostaining of atrial sections from 
HIES-challenged Nrf2-knockout mice revealed signifi-
cantly higher levels of HNE-modified protein adducts 
(2.73  ±  0.09) than the age-matched WT counterparts 
(2.19 ± 0.22) (Fig. 5a, b, column 3 vs 4) indicating a posi-
tive correlation of HNE-Michael adducts formation along 
with ROS induction in the atria.
HIES promotes accumulation of ubiquitinated proteins 
in the Nrf2−/− atria
The ubiquitin system helps maintain a protein qual-
ity control (PQC) and a tight cross-talk exists between 
ubiquitin and redox homeostasis [40]. As cardiomyo-
cyte size is a tightly regulated process comprising of bal-
anced anabolic and catabolic events, any perturbations 
in ubiquitin pools and the related pathway could have 
profound effects on either accrual or removal of key pro-
teins thereby affecting the structure as well as function. 
Thus, we sought to determine if there are any changes in 
ubiquitin levels in our experimental conditions using an 
antibody that detects both free and conjugated ubiquitin 
in an immunofluorescence assay. Under sedentary condi-
tions, we did not observe any significant staining pattern 
of ubiquitin immunoreactivity in atria among WT, but 
Nrf2−/− animals displayed low–moderate levels of ubiq-
uitinated proteins (Fig. 5c, d). While we observed a sig-
nificant increase in the ubiquitin reactivity in WT mice 
after HIES, it was not significantly different from the 
basal Nrf2−/− atria (Fig.  5d). Notably, in a HIES model, 
Nrf2-knockout exhibited an intense ubiquitin staining 
of atrial tissue that is largely confined to the cytoplasm, 
with negligible to nil nuclear staining when compared 
with WT (Fig. 5c, d). The average atrial ubiquitin staining 
score of Nrf2−/− underwent HIES (7.43 ±  0.2) was sig-
nificantly higher than that of the corresponding WT mice 
(4.03 ± 0.77) (Fig. 5d). Altogether, this data indicated that 
pools of ubiquitin and its conjugated proteins are higher 
in atria of Nrf2-disrupted mice subjected to HIES, and 
its abundance may be associated with increased vulner-
ability of atrium to oxidative injury mediated structural 
remodeling.
Impaired autophagy response is evident in Nrf2−/− 
after HIES
Due to increased ubiquitination in response to HIES 
and since the Nrf2 pathway has been reported to play 
a critical role in autophagy mechanism, we next sought 
to evaluate the status of autophagy in this setting. The 
impact of HIES on atrial autophagic activity in the WT 
and Nrf2−/− mice was evaluated by determining the 
expression of LC3, a marker of autophagosome [41], and 
Atg7, a critical rate limiting factor for autophagosome 
formation [42]. Immunofluorescence analysis revealed 
that there was a significant decrease of LC-3 staining 
in the Nrf2−/− mice under sedentary when compared 
to WT animals (Fig.  6a). After HIES stimulation, the 
LC3 levels were significantly increased in WT animals, 
but this response was less pronounced in Nrf2−/− atria 
(Fig.  6a, b). An increasing response of ATG7-positive 
structures was noted in atria of Nrf2−/− after HIES when 
compared to Nrf2−/− sedentary mice (Fig.  6a, c) imply-
ing activation of the autophagy process. Further, double 
immunostaining of ATG7/ubiquitin revealed an exten-
sive cytoplasmic co-localization of ubiquitin and ATG7 
on both large pleomorphic and small puncta structures 
along with increased number of ubiquitin/ATG7 dou-
ble positive counts in Nrf2−/− mice challenged with 
HIES when compared with WT that underwent HIES 
(Fig. 6a, d; white arrows (lower panel). In contrast, they 
were either barely or mildly detected under the seden-
tary state. Altogether, these results suggest that the loss 
of Nrf2 can exaggerate HIES-impaired autophagosome 
formation and result in accumulation of toxic proteins in 
the atria.
Discussion
The atrium is a dynamic organ that instigates electric 
signals to the ventricle to successively beat and facilitate 
blood circulation to peripheral organ systems. While 
redox homeostasis is critical for the regulation of basal 
cellular signaling events, its shift towards oxidative stress 
along with an impaired antioxidant system is expected 
to be detrimental and leads to end-organ damage. The 
atrium being such an important organ system, its expo-
sure to oxidative stress is shown to structurally and elec-
trically remodel and result in atrial fibrosis and/or atrial 
fibrillation. In the present study, we investigated whether 
genetic ablation of the master regulator of antioxidants 
namely, nuclear erythroid derived factor-2 (Nfe2L2 or 
Nrf2) could induce pathological atrial remodeling in a 
human equivalence of late middle-aged mice undergo-
ing high intensity exercise stress (HIES). Our findings 
indicate that (i) loss of this transcription factor results 
in differential regulation of antioxidant systems in the 
atria, (ii) HIES induces adaptive hypertrophy response 
in WT, but the Nrf2-null mice exhibit pathological atrial 
remodeling, (iii) WT mice maintains glutathione levels 
after HIES, but Nrf2−/− exhibit depletion of GSH and 
(iv) profound oxidative stress observed in Nrf2-null mice 
























































Fig. 5 Determination lipid peroxidation by 4‑HNE‑fluorescence analysis and poly‑ubiquitination in WT and Nrf2−/− mice. a IF analysis using anti‑
4HNE‑ab (1:500; v/v) showing increased HNE adducts in WT and Nrf2–/– mice. Blue: nucleus (DAPI); Green: Anti‑4HNE staining. b Anti‑4HNE intensity 
was calculated as fold change of mean values of the WT sedentary group and the data is represented as mean ± SEM in the histograms (n = 3–4/
group). c IF of poly‑ubiquitination in WT and Nrf2−/− mice. Images were obtained under confocal microscope at a magnification of 60x oil immersion. 
Blue: nucleus (DAPI); Green: Ubiquitinated proteins. d Intensity analysis of ubiquitinated proteins showing ~ fivefold increase in Nrf2−/− subjected HIES 
when compared to WT HIES or WT‑sedentary mice (n = 3–4/group). *P < 0.05 vs SED WT; #P < 0.05 vs SED Nrf2–/– and $P < 0.05 vs HIES WT
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subjected to HIES was associated with increased ubiqui-
tination resulting in impaired autophagic mechanisms. 
Altogether, our results suggest a critical role for Nrf2 
in maintaining the gene indices responsible for optimal 
atrial efficiency in response to HIES (Fig. 7).
Hypertrophy is accompanied by changes in expression 
of specific genes [43–45]. In the 20–22 months old WT 
mice, HIES significantly induced the expression of hyper-
trophic markers, Anf and Bnf with no change in α-Mhc 
(Myh6) and β-Mhc (Myh7) expression. On the other 
hand, ablation of Nrf2 along with high intensity exercise 
resulted in a several fold increase in the transcript lev-
els of markers of hypertrophy (Fig.  1). Surprisingly, the 
β-Mhc expression was significantly increased without a 
change in α-Mhc in response to HIES in the Nrf2−/− atria. 
This result is in accordance with the previous reports that 
upon atrial hypertrophy, MHC isozyme undergo a transi-
tion from α-MHC to β-MHC [46–48]. Furthermore, the 
differential MHC isoenzyme distribution observed in 
Nrf2−/− mice subjected to HIES could indicate a patho-
logical structural remodeling of the atria as reported in 
various pathological conditions such as diabetes, dwarf-
ism, adrenalectomy and gonadectomy [49–53].
A progressive decline in overall antioxidant mecha-
nisms is strongly associated with profound oxidative 
stress with advancing age, which is believed to be a 
causal factor for various pathological processes includ-
ing cardiovascular diseases. Although several studies 
have reported a strong role for Nrf2 in various organ 
systems [15, 38], there is no information available on its 
role in the atrial tissue. Current observations show evi-
dence for impaired antioxidant mechanisms due to the 
loss of Nrf2 in the atria. Under unstressed conditions, 
downregulation of some of the antioxidants at the level 
of transcription and translation was noted in association 
with ablation of Nrf2 in late middle-aged (20–22 months) 
mice. Interestingly, sustained strain created by HIES 
intensified the impairment of selective antioxidant genes/
proteins in atria due to Nrf2 ablation. Nonetheless, the 
atria of WT animals found to either retain or partially 
induce the transcription/translation of some of the anti-
oxidants (GSR and NQO1) in response to HIES. These 
observations in WT mice recalls our previous finding 
that acute exercise activating Nrf2-antioxidant signaling 
in young-adult mice hearts [25]. Similar studies related 
to active versus sedentary life style in humans indicated 
impaired activation of Nrf2-signaling in aged skeletal 
muscle [18, 38]. Here, the genetic ablation of Nrf2 com-
bined with HIES significantly but selectively impacted 
the antioxidant system in atria plausibly due to switching 
and/or availability of co-factors controlling the transcrip-
tional events which are stressor-specific that influences 
distinct pathways and regulatory factors [54].
Oxidative stress coupled with advancing age is believed 
to cause a variety of biochemical and conformational 
alterations in macromolecules [55–57]. Under a chronic 
setting, these changes along with prolonged antioxidant 
depletion in organelles and cells result in impaired PQC 
and organ dysfunction. Several studies have reported 
that increased ROS/RNS generation and oxidative/nitro-
sative stress contribute to several age-associated dis-
eases including cardiovascular complications in humans 
[9, 44, 52, 58, 59]. Declined Nrf2 signaling is associated 
with increased oxidative stress in the skeletal muscle of 

















Fig. 7 Proposed model displaying the effects of high intensity endur‑
ance stress (HIES) on atrial remodeling on aging and/or under Nrf2 
ablation
(See Figure on previous page.) 
Fig. 6 Determination of autophagy proteins (LC3 & ATG7) in WT and Nrf2−/− in response to HIES. a IF analysis of autophagy antibodies LC3 (1:500; 
v/v) and ATG7 (1:500; v/v) and double immunostaining of ATG7/Ubiquitin (1:500; v/v). Blue: nucleus (DAPI); Green: localizes LC3; Red/Green merge (Yel-
low): ATG7/Ubiquitin. b Fluorescence intensity was calculated as fold change of mean values of the WT sedentary group and the data is represented 
as mean ± SEM in the histograms (n = 3–4/group). *P < 0.05 vs SED WT; #P < 0.05 vs SED Nrf2−/− and $P < 0.05 vs HIES WT
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with advancing age [60]. Here, 20–22  months old WT 
mice displayed increased oxidative stress and impaired 
antioxidant system in atria after HIES, that was further 
magnified in the Nrf2−/− mice due to the loss of induc-
ible cytoprotective mechanisms. Maintenance of mod-
erate levels of antioxidant system components is central 
to govern the intracellular oxidant load and protect 
the cells/organs from oxidative stress [32]. In the cur-
rent study, alteration of redox homeostasis due to Nrf2 
abrogation enhanced the extent of atrial ubiquitination 
in response to HIES. In addition, we found that 4-HNE 
modified proteins, end products of lipid peroxidation 
were significantly elevated in HIES-subjected Nrf2-null 
mice when compared with its WT counterparts. Since 
high levels of ubiquitination and 4-HNE are reported to 
induce cardiac hypertrophy, cellular damage and apopto-
sis in the heart [61–66], the significantly elevated levels 
of 4-HNE modified proteins along with ubiquitination 
that we found after HIES in Nrf2-null animals may result 
in pathological atrial hypertrophy. Therefore, a balanced 
action of Nrf2 signaling is vital to preserve atrial antioxi-
dant defense and redox homeostasis.
While reduced autophagy has been related to acceler-
ated aging, activation of autophagy might have potent 
anti-aging effects [67, 68]. Interestingly, while exercise 
stress activates autophagy response (LC3) in WT and 
Nrf2−/− atria, the degree of accumulation of ubiquit-
inated proteins is significantly increased in the Nrf2−/− 
when compared to WT mice in response to HIES. In 
particular, co-staining of ATG7 with poly-ubiquitin-anti-
body (Fig. 6a,d) suggests its ubiquitination indicating an 
impairment in autophagy function in the Nrf2−/− atria. 
ATG7 is a key rate limiting component of autophagy 
pathway that regulates the formation of autophagosome 
for further presentation to the lysosome to form the 
autophagolysosome [69]. Besides autophagy being an 
adaptive response to stress and maintain PQC in cells, 
it has been reported to have a prominent role in defin-
ing the life span of many model organisms [70]. Of note, 
under HIES setting, a higher degree of impairment in 
autophagic response (due to ubiquitination of ATG7) 
observed in Nrf2−/− in relation to WT mice might form 
the basis for compromised PQC and accumulation 
of degraded proteins in the atrial myocytes, and  may 
explain the plausible mechanism for pathological remod-
eling of Nrf2−/− atria. Recently, a unique form of ubiqui-
tin-dependent autophagy in protein aggregate clearance 
with relevance to multiple pathological setting is increas-
ing [71–73]. Furthermore, our data on the impaired 
ubiquitination system and autophagic mechanisms due 
to loss of Nrf2 could complicate the treatment strategies 
as recently, it has been documented that a collaborative 
action between autophagy and ubiquitination is essential 
to target an oncogenic protein for prevention or therapy 
[74].
Conclusions
The fundamental observations presented here suggests 
that loss of Nrf2 could have independent and/or uncon-
ventional effects beyond antioxidant control in that it 
could either directly or indirectly be involved in deregu-
lating the gene indices associated with increased ubiq-
uitination and impaired autophagy leading to atrial 
hypertrophy. In terms of HIES, WT atria are character-
ized by mild to a modest increase in genes associated 
with hypertrophy and antioxidant systems that are con-
trolling structure-function characteristics of atria hint-
ing at a physiological adaptation. However, Nrf2-null 
atria displayed a greater magnitude of changes in the 
aforementioned parameters beyond optimal adaptation. 
Our current study using the whole body Nrf2-KO model 
emphasizes that the loss of Nrf2 can reduce key cytopro-
tective proteins and could blunt the protective response 
to exercise induced-oxidative stress in aged animals thus 
trigger a pathological remodeling of the atria. In other 
words, the vital requirement of Nrf2 to obtain the ben-
efits of exercise is mandatory during aging and in addi-
tion, manipulating the Nrf2-ARE signaling could likely be 
a potential means to mitigate atrial maladaptations and 
damages that occur during age-associated fibrotic remod-
eling and atrial fibrillation. In conclusion, we propose that 
loss of Nrf2 could switch the physiological adaptation to 
pathological phenotype in human equivalence of late mid-
dle-aged atria undergoing high intensity exercise stress.
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